Back
argenx SE Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
57
ARGX
argenx SE
Last Price:
563.90
Seasonality Move:
34.25%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.81
Seasonality Move:
32.46%
Buy
57
argenx SE (ARGX)
is a Buy
Is argenx SE a Buy, Sell or Hold?
- The current argenx SE [ARGX] share price is $568.49. The Score for ARGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- ARGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.81. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
ARGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.81 | Buy |
| Relative Strength Index (14 RSI): | 64.09 | Buy |
| Chaikin Money Flow: | 189427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (524.61 - 551.27) | Buy |
| Bollinger Bands (100): | (430.08 - 545.42) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 30.34 | Sell |
| Chaikin Money Flow: | -186102 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.86 - 0.98) | Sell |
| Bollinger Bands (100): | (0.92 - 1.2) | Sell |
ARGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 548.36 | Buy |
| 20-day SMA: | 539.95 | Buy |
| 50-day SMA: | 533.18 | Buy |
| 200-day SMA: | 435.33 | Buy |
| 8-day EMA: | 551.97 | Buy |
| 20-day EMA: | 542.6 | Buy |
| 50-day EMA: | 526.29 | Buy |
| 200-day EMA: | 466.01 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.86 | Sell |
| 20-day SMA: | 0.9 | Sell |
| 50-day SMA: | 1.03 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.85 | Sell |
| 20-day EMA: | 0.9 | Sell |
| 50-day EMA: | 0.99 | Sell |
| 200-day EMA: | 1.06 | Sell |
argenx SE Earnings Growth & ARGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.69 per share, and an increase next year of $6.40 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
argenx SE Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||